WO2006114611A3 - Materials and methods relating to the diagnosis of cancer - Google Patents

Materials and methods relating to the diagnosis of cancer Download PDF

Info

Publication number
WO2006114611A3
WO2006114611A3 PCT/GB2006/001510 GB2006001510W WO2006114611A3 WO 2006114611 A3 WO2006114611 A3 WO 2006114611A3 GB 2006001510 W GB2006001510 W GB 2006001510W WO 2006114611 A3 WO2006114611 A3 WO 2006114611A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
diagnosis
materials
methods relating
methods
Prior art date
Application number
PCT/GB2006/001510
Other languages
French (fr)
Other versions
WO2006114611A2 (en
Inventor
Elena Klenova
Igor Chernukin
France Docquier
Arcy Vivien D
Dawn Farrar
Original Assignee
Cancer Rec Tech Ltd
Elena Klenova
Igor Chernukin
France Docquier
Arcy Vivien D
Dawn Farrar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd, Elena Klenova, Igor Chernukin, France Docquier, Arcy Vivien D, Dawn Farrar filed Critical Cancer Rec Tech Ltd
Publication of WO2006114611A2 publication Critical patent/WO2006114611A2/en
Publication of WO2006114611A3 publication Critical patent/WO2006114611A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Abstract

Methods of diagnosing cancer or pre-cancerous conditions are disclosed involving the detection of CTCF.
PCT/GB2006/001510 2005-04-25 2006-04-25 Materials and methods relating to the diagnosis of cancer WO2006114611A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0508356A GB0508356D0 (en) 2005-04-25 2005-04-25 Materials and methods relating to the diagnosis of cancer
GB0508356.3 2005-04-25

Publications (2)

Publication Number Publication Date
WO2006114611A2 WO2006114611A2 (en) 2006-11-02
WO2006114611A3 true WO2006114611A3 (en) 2006-12-21

Family

ID=34640099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/001510 WO2006114611A2 (en) 2005-04-25 2006-04-25 Materials and methods relating to the diagnosis of cancer

Country Status (2)

Country Link
GB (1) GB0508356D0 (en)
WO (1) WO2006114611A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102095854A (en) * 2010-11-30 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 Novel application of CTCF (CCCCCT-binding factor) protein
KR101797282B1 (en) 2015-03-26 2017-11-13 연세대학교 산학협력단 A role of ctcf gene in atopic and allergic disease
CN106913861B (en) * 2017-02-28 2020-02-21 上海交通大学医学院附属第九人民医院 Application of CTCF trap protein in preparation of anti-uveal melanoma drugs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972643A (en) * 1994-06-17 1999-10-26 Fred Hutchinson Cancer Research Center Isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972643A (en) * 1994-06-17 1999-10-26 Fred Hutchinson Cancer Research Center Isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KLENOVA ELENA M ET AL: "The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer", SEMINARS IN CANCER BIOLOGY, vol. 12, no. 5, October 2002 (2002-10-01), pages 399 - 414, XP002321011, ISSN: 1044-579X *
YU WENQIANG ET AL: "Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation", NATURE GENETICS, vol. 36, no. 10, October 2004 (2004-10-01), pages 1105 - 1110, XP002398492, ISSN: 1061-4036 *

Also Published As

Publication number Publication date
GB0508356D0 (en) 2005-06-01
WO2006114611A2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2007047408A3 (en) Promac signature application
GB0521521D0 (en) Diagnostic methods and kits
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
EP1968648A4 (en) Diagnostic system for the detection and diagnosis of skin cancer
EP1888765A4 (en) Methods and compositions for the diagnosis of venous thromboembolic disease
WO2006128167A3 (en) Optical coherence tomographic detection of cells and compositions
WO2007089911A3 (en) Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
EP1931979A4 (en) Microfluidic detection of analytes
GB0724881D0 (en) Methods for the detection of colorectal cancer
WO2006050341A3 (en) Modified streptococcal polysaccharides and uses thereof
BRPI0718850A2 (en) METHODS OF TREATING, DIAGNOSING OR DETECTION CANCER
IL178472A0 (en) Three time point lung cancer detection, diagnosis and assessment of prognosis
WO2007038264A3 (en) Gapr-1 methods
WO2009141679A3 (en) Ceacam1 based point-of-care cancer diagnostic
WO2006114611A3 (en) Materials and methods relating to the diagnosis of cancer
WO2007114954A3 (en) Methods, compositions, and kits for the detection and monitoring of kidney cancer
WO2008030559A3 (en) Methods, compositions, and kits for the detection and monitoring of colon cancer
ZA200810695B (en) Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker
WO2006086499A3 (en) Nucleozymes and methods of use
IL188920A0 (en) Normalization of complex analyte mixtures
WO2007130726A3 (en) Methods for the detection of cancer
WO2007120753A3 (en) Methods, compositions, and kits for the detection and monitoring of bladder cancer
WO2006137551A1 (en) Diagnostic method for cancer and diagnostic method for lung cancer
EP1851341A4 (en) Diagnostic methods for early cancer detection
EP1845156A4 (en) Gene specific to cancer and diagnosis kit using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06726899

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6726899

Country of ref document: EP